We are live on
!
Find out more
CRC
Catawba River Capital Portfolio holdings
AUM
$223M
1-Year Est. Return
24.34%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+24.34%
3 Year Est. Return
+89.48%
5 Year Est. Return
+91.16%
10 Year Est. Return
–
AUM
$223M
AUM Growth
+$15.5M
(+7.4%)
Cap. Flow
+$3.91M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
71.94%
Holding
26
New
2
Increased
15
Reduced
6
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadre Holdings
CDRE
|
+$10.2M |
| 2 |
Novanta
NOVT
|
+$7.56M |
| 3 |
RMIX
Suncrete Inc
RMIX
|
+$3.81M |
| 4 |
QXO
QXO Inc
QXO
|
+$818K |
| 5 |
Fidelity Total Bond ETF
FBND
|
+$347K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$13M |
| 2 |
Roper Technologies
ROP
|
+$5.58M |
| 3 |
Full House Resorts
FLL
|
+$763K |
| 4 |
Perimeter Solutions
PRM
|
+$159K |
| 5 |
DBL
DoubleLine Opportunistic Credit Fund
DBL
|
+$44.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 50.79% |
| 2 | Materials | 11.71% |
| 3 | Consumer Discretionary | 5.56% |
| 4 | Technology | 3.79% |
| 5 | Healthcare | 3.44% |
Similar funds
PCM
SPAS
TS
NWMP
GCM
OWG
CCM
SONJCPFA
Catawba River Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Catawba River Capital held 26 positions worth $223M, up 7.4% from $208M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Catawba River Capital's Q2 2026 filing shows 2 new, 15 increased, 6 reduced and 2 closed positions. Its largest new stake was Novanta: 52,245 shares worth $8.48M. The largest sale was Regeneron Pharmaceuticals, an estimated $13M.
By sector, the portfolio is most concentrated in Industrials at 51% of assets, up from 46% a quarter earlier, followed by Materials and Consumer Discretionary.
- Catawba River Capital's largest Q2 2026 buy was Novanta: 52,245 shares worth $8.48M.
- Catawba River Capital added most to Cadre Holdings in Q2 2026, an estimated $10.2M increase.
- Catawba River Capital's biggest Q2 2026 reduction was Full House Resorts, cutting an estimated $763K.
- Catawba River Capital fully exited Regeneron Pharmaceuticals in Q2 2026, selling an estimated $13M.
- Catawba River Capital's ten largest holdings make up 72% of its $223M portfolio in Q2 2026.
- Catawba River Capital opened 2 new positions and closed 2 in Q2 2026.
- Catawba River Capital's portfolio value rose 7.4% quarter-over-quarter to $223M.
Based on Catawba River Capital's 13F filing for Q2 2026, filed 22 Jul 2026.